About Advanced Oncological Hyperthermia
Revolutionizing Cancer Care through Precision and Social Responsibility
Global Leadership in Medical Innovation
Andromedic Srl is a key player in the global hyperthermia medical devices market, specializing in the development of the HyDeep 600 WM—one of the world’s most technologically advanced devices for deep local modulated RF hyperthermia (mHT).
Founded in 1994 in Italy, Andromedic has established a consolidated reality in the field of technical assistance and sales of high-end electromedical equipment. In 2012, driven by technological success and global demand, the Oncological Hyperthermia Division became an independent entity, focusing exclusively on precision oncological solutions.
Premium Wellness Distrib SRL is the official authorized partner and distributor for Andromedic Srl and the von Ardenne Institute Dresden (producers of advanced water-filtered infrared-A whole-body hyperthermia devices).
Professional Expertise & Clinical Track Record
Since 2017, our specialized staff has been integrating deep local hyperthermia (mHT) and whole-body hyperthermia (wIRA) in conjunction with conventional and integrative cancer treatments. Our clinical approach is focused on improving patient outcomes through evidence-based thermal oncology.
Our leadership team is trained and certified by the President of the German Society for Hyperthermia (DGHT), ensuring that all protocols meet the highest European quality and safety standards[cite: 1, 4].
M.Sc. Cristian Gologan
CEO & Engineer
Dr. med. Veronica Iatan
Integrative Medicine Specialist
Our Social & Scientific Mission (SRHO)
The Romanian Society of Hyperthermic Oncology (SRHO , a member of ESHO and of DGHT eV) operates as a scientific-medical entity and a registered Social Enterprise.
In strict accordance with its Constitutive Act and social economy legislation (Law no. 219/2015), SRHO reinvests a minimum of 90% of its profit/surplus back into its social mission. Our goal as as CSO is to democratize access to life-extending oncological hyperthermia, ensuring HT becomes a widely accessible clinical solution for cancer patients in Romania, improving OS and QoL.
- Standardizing clinical protocols to international ESHO/DGHT benchmarks
- Providing educational support and counseling for patients based on peer-reviewed evidence.
- Strategic advocacy to include hyperthermia in national standard treatment protocols.
Contact Our Specialists
For clinical partnerships, technical specifications, or specialized consultations, please reach out to our team:
Phone: +40758638401 (M.Sc. Cristian Gologan, CEO)
Phone: +40723791014 (Dr. med. Veronica Iatan)
Email: [email protected]